Cassava Sciences | PTIE - Loan Capital


Cassava Sciences reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Amgen USD 51.89B 1.88B Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 134.78B 12M Mar/2026
Eli Lilly USD 39.37B 1.5B Mar/2026
Geron USD 119.83M 286K Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Merck USD 46.67B 77M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Novavax USD 246.3M 200K Dec/2025
Pfizer USD 60.57B 1.08B Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025